These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22744718)

  • 1. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
    Chalmers JD; Smith MP; McHugh BJ; Doherty C; Govan JR; Hill AT
    Am J Respir Crit Care Med; 2012 Oct; 186(7):657-65. PubMed ID: 22744718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis.
    Sibila O; Laserna E; Shoemark A; Keir HR; Finch S; Rodrigo-Troyano A; Perea L; Lonergan M; Goeminne PC; Chalmers JD
    Am J Respir Crit Care Med; 2019 Jul; 200(1):33-41. PubMed ID: 31109172
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
    Laska IF; Crichton ML; Shoemark A; Chalmers JD
    Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
    Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
    Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
    Paredes Aller S; Quittner AL; Salathe MA; Schmid A
    Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.
    Goldman N; Loebinger MR; Wilson R
    Expert Rev Respir Med; 2016 Dec; 10(12):1259-1268. PubMed ID: 27820964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
    Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J
    Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
    Xu MJ; Dai B
    Ther Adv Respir Dis; 2020; 14():1753466620936866. PubMed ID: 32615859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term antibiotics in the management of non-CF bronchiectasis--do they improve outcome?
    Evans DJ; Greenstone M
    Respir Med; 2003 Jul; 97(7):851-8. PubMed ID: 12854637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
    Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review.
    Brodt AM; Stovold E; Zhang L
    Eur Respir J; 2014 Aug; 44(2):382-93. PubMed ID: 24925920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.
    Brill SE; Patel AR; Singh R; Mackay AJ; Brown JS; Hurst JR
    Respir Res; 2015 Feb; 16(1):16. PubMed ID: 25849856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
    Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
    Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.
    Choo JM; Abell GCJ; Thomson R; Morgan L; Waterer G; Gordon DL; Taylor SL; Leong LEX; Wesselingh SL; Burr LD; Rogers GB
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.